TREATMENT OR PROPHYLAXIS OF PROSTATIC CANCER AND BENIGN PROSTATIC HYPERPLASIA WITH SELECTIVE ESTROGEN RECEPTOR MODULATORS - Patent 0975629

(19)

(11)

EP 0 975 629 A1

(12)

(43)	Date of publication:
	02.02.2000 Bulletin 2000/05

(21)	Application number: 98915488.5

(22)	Date of filing: 07.04.1998

(51)	International Patent Classification (IPC)⁷: C07D 409/12, A61K 31/535, A61K 31/38

(86)	International application number:
	PCT/US9807/274

(87)	International publication number:
	WO 9845/288 (15.10.1998 Gazette 1998/41)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE
	Designated Extension States:
	AL LT LV RO SI

(30)

Priority:

09.04.1997 US 43223 P

(71)	Applicant: ELI LILLY AND COMPANY
	Indianapolis, Indiana 46285 (US)

(72)	Inventor:
	NEUBAUER, Blake, Lee Indianapolis, IN 46220-1025 (US)

(74)	Representative: Denholm, Anna Marie et al
	Eli Lilly and Company Limited,Lilly Research Center,Erl Wood Manor Windlesham,Surrey GU20 6PH Windlesham,Surrey GU20 6PH (GB)

(54)	TREATMENT OR PROPHYLAXIS OF PROSTATIC CANCER AND BENIGN PROSTATIC HYPERPLASIA WITH SELECTIVE ESTROGEN RECEPTOR MODULATORS